Product Description
Explore the kingly benefits of BCG Vaccine Oncovac, offered in a convenient 1 vial hospital packaging, designed exclusively for healthcare professionals. Utilise this unmatchable offer to access instant savings while protecting at-risk populations with a wondrous, proven solution. Oncovac contains Bacillus Calmette-Guerin (BCG) live attenuated vaccine in a sterile, preservative-free formulation. Ideal for the prevention of tuberculosis and as immunotherapy for bladder cancer, this product guarantees efficacy and safety, provided under regulatory Schedule H status. Requires reconstitution with the included sterile saline ampoule for intradermal or intravesical administration in clinical settings only.
Distinct Application & Specialized Utility
BCG Vaccine Oncovac is applied via intradermal injection for tuberculosis prevention, or intravesical installation in bladder cancer immunotherapy. Its kingly formulation, with live attenuated Mycobacterium bovis, comes as a lyophilized powder requiring reconstitution with sterile saline. This wondrous, sterile and single-use vaccine is exclusively for hospital and healthcare professional administration, ensuring unmatchable safety standards. It is odorless, with a white to off-white appearance, and should be used strictly according to prescription and regulatory guidelines.
Packaging Valuation & Market Availability
Each Oncovac pack includes one vial and one ampoule of sterile saline, carefully packed to maintain stability and extend its 24-month shelf life. Available at the lowest price for bulk hospital procurement, the product is offered by recognized exporters, suppliers, and traders across India. Secure payment terms, efficient valuation, and reliable transport services ensure seamless delivery throughout the main domestic market, guaranteeing instant savings and dependable supply for healthcare facilities.
FAQ's of Bcg Vaccine Oncovac For Hospital Packaging Size 1 Vial:
Q: How should BCG Vaccine Oncovac be administered in hospital settings?
A: BCG Vaccine Oncovac is administered either intradermally for tuberculosis prevention or through intravesical instillation for bladder cancer immunotherapy, only by trained healthcare professionals.
Q: What is the process for reconstituting the BCG Vaccine Oncovac?
A: Before use, the lyophilized powder must be reconstituted with the provided ampoule of sterile saline, following strict aseptic technique to maintain its sterility and efficacy.
Q: When is the use of BCG Vaccine Oncovac contraindicated?
A: It is contraindicated in individuals with immunosuppression or active tuberculosis infection, and should only be used after proper medical evaluation.
Q: Where should BCG Vaccine Oncovac be stored prior to use?
A: Store the vaccine at a temperature between 2C to 8C. It must not be frozen to preserve its stability and effectiveness.
Q: What are the primary benefits of utilising the BCG Vaccine Oncovac in hospitals?
A: The primary benefits include the prevention of tuberculosis and immunotherapy for bladder cancer, delivered through a sterile, single-use, preservative-free formulation with a high safety profile.